184 related articles for article (PubMed ID: 1873713)
1. Clinical significance of the large adrenal mass.
Khafagi FA; Gross MD; Shapiro B; Glazer GM; Francis I; Thompson NW
Br J Surg; 1991 Jul; 78(7):828-33. PubMed ID: 1873713
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours.
Maurea S; Klain M; Caraco C; Ziviello M; Salvatore M
Nucl Med Commun; 2002 Oct; 23(10):951-60. PubMed ID: 12352593
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic dilemma of small incidentally discovered adrenal masses: role for 131I-6beta-iodomethyl-norcholesterol scintigraphy.
Kloos RT; Gross MD; Shapiro B; Francis IR; Korobkin M; Thompson NW
World J Surg; 1997 Jan; 21(1):36-40. PubMed ID: 8943175
[TBL] [Abstract][Full Text] [Related]
4. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
Maurea S; Caracò C; Klain M; Mainolfi C; Salvatore M
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):188-97. PubMed ID: 15499292
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing benign from malignant euadrenal masses.
Gross MD; Shapiro B; Bouffard JA; Glazer GM; Francis IR; Wilton GP; Khafagi F; Sonda LP
Ann Intern Med; 1988 Oct; 109(8):613-8. PubMed ID: 3421574
[TBL] [Abstract][Full Text] [Related]
6. High risk of malignancy in patients with incidentally discovered adrenal masses: accuracy of adrenal imaging and image-guided fine-needle aspiration cytology.
Lumachi F; Borsato S; Tregnaghi A; Marino F; Fassina A; Zucchetta P; Marzola MC; Cecchin D; Bui F; Iacobone M; Favia G
Tumori; 2007; 93(3):269-74. PubMed ID: 17679462
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses.
Maurea S; Klain M; Mainolfi C; Ziviello M; Salvatore M
J Nucl Med; 2001 Jun; 42(6):884-92. PubMed ID: 11390552
[TBL] [Abstract][Full Text] [Related]
8. The role of adrenocortical scintigraphy in the evaluation of unilateral incidentally discovered adrenal and juxtaadrenal masses.
Nakajo M; Nakabeppu Y; Yonekura R; Iwashita S; Goto T
Ann Nucl Med; 1993 Aug; 7(3):157-66. PubMed ID: 8217490
[TBL] [Abstract][Full Text] [Related]
9. [The role of adrenal gland x-ray computed tomography and scintigraphy using radiolabelled norcholesterol in the etiological diagnosis of primary hyperaldosteronism].
Abram M; Peltier P; Murat A; Chupin M; Dupas B; Gaillard F; Chatal JF; Charbonnel B
Rev Med Interne; 1993; 14(7):691-7. PubMed ID: 8191071
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of iodine-131-iodocholesterol in renal cell carcinoma adrenal metastases.
Tsukamoto E; Itoh K; Kanegae K; Kobayashi S; Koyanagi T; Tamaki N
J Nucl Med; 1998 Apr; 39(4):656-8. PubMed ID: 9544676
[TBL] [Abstract][Full Text] [Related]
11. Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI.
Maurea S; Cuocolo A; Reynolds JC; Tumeh SS; Begley MG; Linehan WM; Norton JA; Walther MM; Keiser HR; Neumann RD
J Nucl Med; 1993 Feb; 34(2):173-9. PubMed ID: 8381474
[TBL] [Abstract][Full Text] [Related]
12. Adrenal masses in oncologic patients: functional and morphologic evaluation.
Francis IR; Smid A; Gross MD; Shapiro B; Naylor B; Glazer GM
Radiology; 1988 Feb; 166(2):353-6. PubMed ID: 3336710
[TBL] [Abstract][Full Text] [Related]
13. Role of 131I-metaiodobenzylguanidine in the localization of suspected phaeochromocytomas.
Khafagi FA; Mortimer RH; Egerton-Vernon JM; Perry-Keene DA
Med J Aust; 1989 Jun; 150(11):639-44. PubMed ID: 2725378
[TBL] [Abstract][Full Text] [Related]
14. [Adrenal gland scintigraphy].
Fischer M; Vetter H
Radiologe; 1986 Apr; 26(4):181-5. PubMed ID: 3012627
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of solid adrenal masses using adrenocortical scintigraphy.
Dominguez-Gadea L; Diez L; Bas C; Crespo A
Clin Radiol; 1994 Nov; 49(11):796-9. PubMed ID: 7955847
[TBL] [Abstract][Full Text] [Related]
16. Quantitative evaluation of norcholesterol scintigraphy, CT attenuation value, and chemical-shift MR imaging for characterizing adrenal adenomas.
Yoh T; Hosono M; Komeya Y; Im SW; Ashikaga R; Shimono T; Tsuchiya N; Okada M; Hanada K; Yagyu Y; Nishimura Y; Murakami T
Ann Nucl Med; 2008 Jul; 22(6):513-9. PubMed ID: 18670858
[TBL] [Abstract][Full Text] [Related]
17. [A comparison of scintigraphy with radioiodinated MIBG and CT in localizing pheochromocytomas].
Rufini V; Troncone L; Valentini AL; Danza FM
Radiol Med; 1988 Nov; 76(5):466-70. PubMed ID: 3205923
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of phaeochromocytoma with 131I-metaiodobenzylguanidine.
Fischer M; Vetter W; Winterberg B; Zidek W; Hengstmann J; Vetter H
J Hypertens Suppl; 1984 Dec; 2(3):S187-9. PubMed ID: 6599667
[TBL] [Abstract][Full Text] [Related]
19. Quantitative imaging characterization of hypersecreting or nonhypersecreting adrenal adenomas: comparison between iodine-131 norcholesterol uptake and magnetic resonance signal intensity ratios.
Maurea S; Imbriaco M; Mollica C; Pace L; Salvatore M
Nucl Med Commun; 2011 Jun; 32(6):535-41. PubMed ID: 21448089
[TBL] [Abstract][Full Text] [Related]
20. The value of 18F-FDG PET-CT and 131I-norcholesterol scintigraphy in the characterization of high-risk adrenal masses.
Riaz S; Syed R; Aziz TA; Alnaim A; Chung TT; Wan S; Kurzawinski TR; Bomanji J
Nucl Med Commun; 2020 Mar; 41(3):189-195. PubMed ID: 31895761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
